HIV 1 News and Research

RSS

USA today examines why aid for Haiti goes unspent

Ten months after the magnitude-7 earthquake that killed 230,000 people and destroyed at least 60% of Haiti's capital city, Port-au-Prince, some relief agencies have not spent the bulk of the donations they raised after the disaster.

2 Dec 2010

Report analyzes global health funding trends, predicts lower funding growth

A report from the Institute for Health Metrics and Evaluation (IHME) finds that the recent global economic downturn "hasn't quelled generous government and private donors from giving record amounts to improve global health," but the analysis also revealed "that growth in funding is beginning to taper off, cut by more than half between 2008 and 2010," the Seattle Times' "The Business of Giving" blog reports (Heim, 11/30).

2 Dec 2010

New cell-based assay for reliable testing of HIV inhibitors

EASY-HIT is a new cell-based assay system for simple and reliable testing of HIV inhibitors. This system was developed under the leadership of Professor Ruth Brack-Werner at the Institute of Virology.

2 Dec 2010

U.N. says PMTCT of HIV is achievable; efforts must target millions currently 'falling through the cracks'

A generation of babies could be born free of AIDS if the international community stepped up efforts to provide universal access to HIV prevention, treatment and social protection, the United Nations said on Tuesday, Reuters reports.

2 Dec 2010

World AIDS day opinions

In a Washington Post opinion piece, former President George W. Bush reflects on his administration's commitment to fight HIV/AIDS around the world. "In all of these efforts, my concern was results.

1 Dec 2010

World AIDS day observed

As the 1st of December is being observed as World AIDS day, UN Secretary-General Ban Ki-moon urged for stronger global efforts in fighting HIV/AIDS, including ensuring universal access to HIV prevention, treatment, care and support, after significant progress has been made over the past three decades.

1 Dec 2010

World AIDS Day to mark start of international effort to shed light on how public funds are used

International development agencies in nine countries -- Austria, Canada, Denmark, Germany, Norway, Spain, Sweden, the United Kingdom and the United States of America-have been asked to explain their criteria for funding HIV and AIDS assistance -- and whether faith-based organizations get special concessions when they apply for public funds to deliver prevention and treatment programs abroad.

1 Dec 2010

Donors donate record amounts for global health despite the worst economic crisis

The worst global economic crisis in decades has not stopped public and private donors from giving record amounts of money to health assistance for developing countries, according to a new report by the Institute for Health Metrics and Evaluation (IHME) at the University of Washington.

1 Dec 2010

OraSure supports rapid HIV testing initiatives to recognize World AIDS Day

OraSure Technologies, Inc., the market leader in oral fluid diagnostics, today announced its support of more than 150 rapid HIV testing initiatives taking place in more than 25 states in the U.S. and numerous countries globally, in recognition of World AIDS Day, commemorated annually on December 1st.

1 Dec 2010

PepTcell changes name to SEEK

PepTcell, a leading UK privately-owned drug-discovery group, today announced it is changing its name to SEEK.

1 Dec 2010

Health, HIV and human rights

On World AIDS Day 2010, the global community is focusing attention on protecting human rights of all people affected by HIV.

1 Dec 2010

Children who care for parents with AIDS have higher level of mental illness

December 1st is World AIDS day. There are 33.4 million people worldwide living with HIV, 67per cent in the Sub-Saharan Africa region. In South Africa alone, 5.6 million people are HIV-positive, with only 22 per cent having access to anti-retroviral medication. A pioneering study, funded by Economic and Social Research Council and the South African National Research Foundation, finds that those children who care for parents with AIDS have a higher level of mental illness.

1 Dec 2010

SPARTAC study examines ways to limit immune system damage in HIV infection

For most people in high-income countries HIV is considered a chronic illness which can be managed with medication. But the virus still causes extensive damage to the immune system, and treatment with antiretrovirals is a lifelong commitment. Once started, usually within three to five years following infection, the course of treatment needs to be strictly followed and taken for life.

1 Dec 2010

Not all HIV viruses are bad for the immune system

Mayo Clinic researchers have shown why, in a minority of HIV patients, immune function improves despite a lack of response to standard anti-retroviral treatment. In these cases, researchers say, the virus has lost its ability to kill immune cells. The findings appear in the online journal PLoS Pathogens.

1 Dec 2010

Bill & Melinda Gates Foundation awards $6M grant to NanoBio to develop intranasal vaccine for RSV

NanoBio Corporation announced today that it has received a $6M grant from the Bill & Melinda Gates Foundation to support the development of a safe and effective intranasal vaccine for Respiratory Syncytial Virus (RSV).

1 Dec 2010

PhRMA reports 100 new medicines and vaccines in development for HIV/AIDS

America's biopharmaceutical research companies are working on 100 new medicines and vaccines [video] to treat and prevent HIV/AIDS and related conditions, according to a new report from the Pharmaceutical Research and Manufacturers of America (PhRMA).

1 Dec 2010

Number of people living with HIV/AIDS in Africa to outpace treatment resources by 2020, IOM report finds

The number of people living with HIV/AIDS in Africa is projected to greatly outpace treatment resources by the end of the decade, according to a report released Monday by the Institute of Medicine (IOM), Reuters reports (Fox, 11/29).

1 Dec 2010

Research on patients' immune system may lead to new diagnostic tool for HIV treatment

1 Dec 2010

Goosby, Emanuel address progress, potential roadblocks ahead for introduction of microbicides in developing countries

The growing evidence supporting the promise of new HIV prevention products, like microbicides, requires that groups start planning now for how best to roll-out prevention interventions in the future, U.S. Global AIDS Coordinator Eric Goosby and Special Advisor on Health Policy to the Director of the White House Office of Management and Budget Ezekiel Emanuel said Monday during a USAID Microbicide Stakeholders Meeting in Washington.

30 Nov 2010

Argos commences dosing in Arcelis personalized immunotherapy Phase 2b clinical trial for HIV

Argos Therapeutics today announced that it has initiated dosing of patients in a Phase 2b clinical trial of its Arcelis™ personalized immunotherapy for the treatment of HIV patients, AGS-004.

30 Nov 2010

HIV 1 News and Research

USA today examines why aid for Haiti goes unspent

Report analyzes global health funding trends, predicts lower funding growth

New cell-based assay for reliable testing of HIV inhibitors

U.N. says PMTCT of HIV is achievable; efforts must target millions currently 'falling through the cracks'

World AIDS day opinions

World AIDS day observed

World AIDS Day to mark start of international effort to shed light on how public funds are used

Donors donate record amounts for global health despite the worst economic crisis

OraSure supports rapid HIV testing initiatives to recognize World AIDS Day

PepTcell changes name to SEEK

Health, HIV and human rights

Children who care for parents with AIDS have higher level of mental illness

SPARTAC study examines ways to limit immune system damage in HIV infection

Not all HIV viruses are bad for the immune system

Bill & Melinda Gates Foundation awards $6M grant to NanoBio to develop intranasal vaccine for RSV

PhRMA reports 100 new medicines and vaccines in development for HIV/AIDS

Number of people living with HIV/AIDS in Africa to outpace treatment resources by 2020, IOM report finds

Research on patients' immune system may lead to new diagnostic tool for HIV treatment

Goosby, Emanuel address progress, potential roadblocks ahead for introduction of microbicides in developing countries

Argos commences dosing in Arcelis personalized immunotherapy Phase 2b clinical trial for HIV

Decoding Cannabis: Differentiating Hemp and Marijuana

Deciphering the Microbiome with The Microsetta Initiative

Leveraging the power of automation to boost research

Latest News